Angiopoietin 2 (Ang-2) as prognosis biomarker in clear cell renal cell carcinoma (ccRCC) patients

被引：0
|
作者：
Boggio, G. [1 ]
Knott, M. E. [2 ]
Grasselli, J. [1 ]
Gandur Quiroga, M. N. [2 ]
Pasik, L. [2 ]
Gueglio, G. [1 ]
Pulero, C. [2 ]
Alvarez, A. [2 ]
Puricelli, L. [2 ]
Pallotta, M. G. [1 ]
机构：
[1] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina
[2] Inst Oncol Angel H Roffo, Buenos Aires, DF, Argentina
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2806
引用
收藏
页码：S677 / S677
页数：1
相关论文
共 50 条
  • [1] Plasma angiopoietin-2 (ANG2) as an angiogenic biomarker in renal cell carcinoma (RCC)
    Bullock, A. J.
    Zhang, L.
    O'Neill, A. M.
    Percy, A.
    Sukhatme, V.
    Mier, J. W.
    Atkins, M. B.
    Bhatt, R. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Prognostic biomarkers in patients with clear cell renal cell carcinoma (ccRCC)
    Gandur Quiroga, Maria N.
    Knott, Maria E.
    Pulero, Carla
    Pasik, Leonardo
    Alvarez, Ana M.
    Brzezinski, Mariano
    Malagrino, Hector
    Bal de Kier Joffe, Elisa D.
    Puricelli, Lydia I.
    [J]. CANCER RESEARCH, 2012, 72
  • [3] FSIP2 can serve as a predictive biomarker for Clear Cell Renal Cell Carcinoma prognosis
    Zhang, Yixiao
    Zhu, Xudong
    Qiao, Xinbo
    Sun, Lisha
    Tian, Ye
    Yang, Yongliang
    Zhao, Yuhong
    Liu, Caigang
    [J]. INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (17): : 2819 - 2825
  • [4] The lipid metabolome of clear cell renal cell carcinoma (CCRCC).
    George, Saby
    Choi, Kyoung-Soo
    Pili, Roberto
    Kazim, Abdul Latif
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Role of Tissue Biomarker Expression in the Prognosis of Clear Cell Renal Cell Carcinoma
    Kim, M. J.
    Sung, W. J.
    Park, D. C.
    [J]. LABORATORY INVESTIGATION, 2009, 89 : 176A - 176A
  • [6] Role of Tissue Biomarker Expression in the Prognosis of Clear Cell Renal Cell Carcinoma
    Kim, M. J.
    Sung, W. J.
    Park, D. C.
    [J]. MODERN PATHOLOGY, 2009, 22 : 176A - 176A
  • [7] Epigenetic differences in NCOA2: a novel biomarker that predicts prognosis in clear cell renal cell carcinoma
    Chen, Zhixian
    Wang, Liang
    Shi, Jian
    Xiao, Wen
    Yuan, Changfei
    Meng, Xiangui
    Ruan, Hailong
    Xiong, Zhiyong
    Zhang, Xiaoping
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (04): : 2515 - 2527
  • [8] SETD2, a histone methyltransferase, is misregulated in advanced clear cell renal cell carcinoma (ccRCC)
    Ho, T. H.
    Monzon, F. A.
    Hoang, A.
    Hung, M. C.
    Jonasch, E.
    [J]. BJU INTERNATIONAL, 2012, 109 : 1 - 2
  • [9] SETD2, a histone methyltransferase, is misregulated in advanced clear cell renal cell carcinoma (ccRCC)
    Ho, Thai H.
    Monzon, Federico A.
    Anh Hoang
    Tamboli, Pheroze
    Furge, Kyle
    Dykema, Karl
    Petillo, David
    Teh, Bin Tean
    Tannir, Nizar
    Jonasch, Eric
    Hung, Mien-Chie
    [J]. CANCER RESEARCH, 2012, 72
  • [10] The lipid metabolomic profile of clear cell renal cell carcinoma (CCRCC)
    George, S.
    Choi, K-S
    Miecznikowski, J.
    Pili, R.
    Kazim, A. L.
    [J]. BJU INTERNATIONAL, 2012, 110 : 15 - 16
12345